The CHMP has recommended approval of Jorveza oral suspension 0.2 mg/mL, the first licensed pediatric formulation of ...

The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect ...

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...

Targeting aging rather than individual diseases could add more than a decade of healthy life, researchers say, citing ...

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a ...

Trabeculectomy as a first-line procedure to treat glaucoma is more cost-effective than tube shunt surgery for people with elevated intraocular pressure (IOP), but tube shunt surgery may be the better ...

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Patients with RA or SLE who adhere to antimalarial therapy have a lower risk for hospital admission and fewer days of hospital stay than their nonadherent peers.